Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-14-005027
Filing Date
2014-09-15
Accepted
2014-09-15 13:50:17
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ctix_10k.htm 10-K 1823236
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ctix_ex23.htm EX-23 3033
3 CERTIFICATION ctix_ex311.htm EX-31.1 15680
4 CERTIFICATION ctix_ex312.htm EX-31.2 16275
5 CERTIFICATION ctix_ex321.htm EX-32.1 5878
6 CERTIFICATION ctix_ex322.htm EX-32.2 6895
  Complete submission text file 0001477932-14-005027.txt   6396923

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ctix-20140630.xml EX-101.INS 707371
8 XBRL TAXONOMY EXTENSION SCHEMA ctix-20140630.xsd EX-101.SCH 69285
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20140630_cal.xml EX-101.CAL 64348
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20140630_def.xml EX-101.DEF 192212
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20140630_lab.xml EX-101.LAB 368348
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20140630_pre.xml EX-101.PRE 283463
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-52321 | Film No.: 141102804
SIC: 2834 Pharmaceutical Preparations